In the realm of immunoassay development, the choice and optimization of buffer solutions are pivotal for ensuring assay sensitivity, specificity, and reproducibility. This webinar aims to delve into the critical role of buffers across various stages of immunoassay development, including, Chemiluminescence Immunoassay (CLIA) and Lateral Flow Assay (LFA). Participants will gain insights into the specific requirements of buffers at different phases of assay development, exploring whether multiple buffers are necessary and the implications of their use in a single assay.
Our session will provide a comprehensive guide on selecting the most suitable buffers for each application while highlighting those that should be avoided due to potential interference with assay components. We will discuss the properties that make certain buffers more effective and provide practical tips for buffer selection to enhance assay performance.
Key learnings from the webinar include:
- Buffer Selection: Criteria for choosing the right buffers for different immunoassay platforms and stages.
- Optimization Tips: Practical advice for buffer optimization to enhance assay sensitivity and specificity.
- Troubleshooting: Strategies for addressing common issues in assay performance due to suboptimal buffering.
This webinar is tailored for professionals and researchers in IVD and Clinical Testing laboratories who are involved in developing Immunoassays Kits and Laboratory Developed Tests (LDT).
Enhance your expertise in buffer optimization, equipping you with the necessary knowledge and tools to refine your assay development processes effectively.
Register now to advance your proficiency in the critical aspects of immunoassay development!
Speakers
Dr. Lisa Fitzpatrick
Merck
Segment Marketing Manager IVD Western Europe
Lisa’s background is in analytical applied chemistry (Ph.D and Post Doctoral studies), with a focus on regulated markets. She has over 20 years’ experience in sales, sales development and marketing with Merck. For the last eight years, she has been involved in the marketing of IVD assay development, and how the regulatory environment impacts the processes that bring a final product to market.
Ella Tang
Merck
Scientist - Application Development Expert
Ella Tang works as Application Development Expert at Merck. Before joining Merck, she worked in ABON Biopharm (Hangzhou) Co., Ltd and Guangzhou Wondfo Biotech Co., Ltd. She has more than 7 years R&D experiences in lateral flow assay. She engaged in POCT product performance optimization and colored latex, fluorescent microsphere conjugation. Meanwhile, Ella Tang was awarded a master’s degree from Northwest Agriculture & Forestry University.
Chengding Lv
Merck
Scientist - Application Development Expert
Chengding Lv works as Application development expert at Merck. He joined Merck in 2022 and engaged in CLIA project optimization and solutions for Diagnostics Manufacturing, providing technical advice and system optimized support for CLIA manufacturing customers. Before joined Merck, Mr. Chengding Lv worked as R&D engineer in Wondfo over 5 years, responsible for the technology and development of CLIA projects and focused on projects of infectious disease. Meanwhile, Chengding Lv earned a Masters in immunology from Jinan University.
Clinical testing and diagnostics manufacturing
- IVD manufacturing
Duration:1h
語言:English
會話 1:提出 October 10, 2024
若要繼續閱讀,請登入或建立帳戶。
還沒有帳戶?